State Street Corp Equillium, Inc. Transaction History
State Street Corp
- $2.25 Trillion
- Q2 2024
A detailed history of State Street Corp transactions in Equillium, Inc. stock. As of the latest transaction made, State Street Corp holds 59,720 shares of EQ stock, worth $49,567. This represents 0.0% of its overall portfolio holdings.
Number of Shares
59,720
Previous 52,620
13.49%
Holding current value
$49,567
Previous $121,000
66.12%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding EQ
# of Institutions
28Shares Held
11.5MCall Options Held
38.1KPut Options Held
0-
Decheng Capital LLC Menlo Park, CA4.45MShares$3.69 Million0.94% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC4.45MShares$3.69 Million1.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA842KShares$698,8160.0% of portfolio
-
Cota Capital Management, LLC San Francisco, CA562KShares$466,6901.37% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny300KShares$249,3320.0% of portfolio
About Equillium, Inc.
- Ticker EQ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,352,100
- Market Cap $28.5M
- Description
- Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...